Return to homepagePandemic Pact

Neutralization of Primate Immunodeficiency Viruses

  • Funded by National Institutes of Health (NIH)
  • Total publications:0 publications

Grant number: 3R01AI036082-28S1

Grant search

Key facts

  • Disease

    COVID-19

  • Start & end year

    1994
    2023

  • Known Financial Commitments (USD)

    $177,065

  • Funder

    National Institutes of Health (NIH)

  • Principal Investigator

    John P Moore

  • Research Location

    United States of America

  • Lead Research Institution

    Weill Cornell Medicine - Cornell University

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

We will repurpose existing assays, techniques and expertise that are central to our project team's virology, structural biology, vaccine development and protein production skill-sets for HIV research, to now also work on SARS-CoV-2 during the COVID-19 pandemic emergency. These interactive research efforts will draw on our established methodologies and should represent a productive use of our existing NIH grant resources. We note that there continue to be institutional restrictions at all three performance sites on the effort that can be applied to our original goals relating to HIV-1 vaccine research and development. Those goals will be unchanged, but will be pursued at a reduced effort during the period when we also work on the new SARS-CoV-2 projects for which we have fewer institutional restrictions due to the COVID-19 pandemic.